![Alicia Goodman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alicia Goodman
Responsable des Ressources Humaines chez CERUS CORPORATION
Postes actifs de Alicia Goodman
Sociétés | Poste | Début | Fin |
---|---|---|---|
CERUS CORPORATION | Responsable des Ressources Humaines | 27/09/2023 | - |
Historique de carrière de Alicia Goodman
Anciens postes connus de Alicia Goodman
Sociétés | Poste | Début | Fin |
---|---|---|---|
AIMMUNE THERAPEUTICS, INC. | Responsable des Ressources Humaines | 01/09/2019 | 01/02/2023 |
NOVARTIS AG | Responsable des Ressources Humaines | - | - |
Berg LLC
![]() Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Responsable des Ressources Humaines | - | - |
Formation de Alicia Goodman
Central Michigan University | Graduate Degree |
Michigan State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Suisse | 2 |
Opérationnelle
Human Resources Officer | 4 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
NOVARTIS AG | Health Technology |
CERUS CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Aimmune Therapeutics, Inc.
![]() Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Berg LLC
![]() Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Health Technology |
- Bourse
- Insiders
- Alicia Goodman
- Expérience